{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:11:00Z","timestamp":1789056660416,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008914","name":"Ontario Brain Institute","doi-asserted-by":"publisher","award":["Ontario Brain Institute"],"award-info":[{"award-number":["Ontario Brain Institute"]}],"id":[{"id":"10.13039\/100008914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00406-026-02362-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:09:03Z","timestamp":1787641743000},"page":"3963-3973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring sex differences in endocannabinoid system biomarkers and their relationship with antidepressant treatment outcomes in major depressive disorder: a CAN-BIND 1 secondary analysis"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4695-9586","authenticated-orcid":false,"given":"Maryam","family":"Sorkhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faranak","family":"Farzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad I.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena C.","family":"Quilty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio N.","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie H.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kloiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"2362_CR1","unstructured":"Collaborators GMD Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019, The Lancet Psychiatry 2022."},{"key":"2362_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1590\/1516-4446-2020-0650","volume":"42","author":"L Guti\u00e9rrez-Rojas","year":"2020","unstructured":"Guti\u00e9rrez-Rojas L, Porras-Segovia A, Andrade-Gonz\u00e1lez N., Cervilla J (2020) . Prevalence and correlates of major depressive disorder: a systematic review. Brazilian J Psychiatry 42:657\u2013672","journal-title":"Brazilian J Psychiatry"},{"key":"2362_CR3","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.jad.2020.07.102","volume":"276","author":"X Guo","year":"2020","unstructured":"Guo X., McCutcheon R. A., Pillinger T., Mizuno Y., Natesan S., Brown K. et al (2020) The magnitude and heterogeneity of antidepressant response in depression: a meta-analysis of over 45,000 patients. J Affect Disord 276:991\u20131000","journal-title":"J Affect Disord"},{"key":"2362_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/07067437241245384","volume":"69","author":"RW Lam","year":"2024","unstructured":"Lam R. W., Kennedy S. H., Adams C., Bahji A., Beaulieu C., Bhat V. et al (2024) Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: R\u00e9seau canadien pour les traitements de l'humeur et de l'anxi\u00e9t\u00e9 (CANMAT) 2023: Mise \u00e0 jour des lignes directrices cliniques pour la prise en charge du trouble d\u00e9pressif majeur chez les adultes. Can J Psychiatry 69:641\u2013687","journal-title":"Can J Psychiatry"},{"key":"2362_CR5","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1055\/a-1872-0844","volume":"55","author":"HK Kim","year":"2022","unstructured":"Kim H. K., Zai G., Muller D. J., Husain M. I., Lam R. W., Frey B. N. et al (2022) Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) Study, Pharmacopsychiatry. 55:297\u2013303","journal-title":"Pharmacopsychiatry"},{"key":"2362_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/YCO.0000000000000562","volume":"33","author":"VL Chadwick","year":"2020","unstructured":"Chadwick V. L., Rohleder C., Koethe D., Leweke F. M (2020) Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans. Curr Opin Psychiatry 33:20\u201342","journal-title":"Curr Opin Psychiatry"},{"key":"2362_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1054\/plef.2001.0360","volume":"66","author":"E Fride","year":"2002","unstructured":"Fride E (2002) Endocannabinoids in the central nervous system-an overview, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA). 66:221\u2013233","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids (PLEFA)"},{"key":"2362_CR8","unstructured":"Crocq M-A (2022) History of cannabis and the endocannabinoid system, Dialogues in clinical neuroscience"},{"key":"2362_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00213-004-1877-8","volume":"176","author":"C Sanchis-Segura","year":"2004","unstructured":"Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology 176:223\u2013232","journal-title":"Psychopharmacology"},{"key":"2362_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/brainsci13020325","volume":"13","author":"A Hasbi","year":"2023","unstructured":"Hasbi A., Madras B. K., George S. R (2023) Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review. Brain Sci 13:325","journal-title":"Brain Sci"},{"key":"2362_CR11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","volume":"370","author":"R Christensen","year":"2007","unstructured":"Christensen R., Kristensen P. K., Bartels E. M., Bliddal H., Astrup A (2007) Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370:1706\u20131713","journal-title":"Lancet"},{"key":"2362_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/138955706776073466","volume":"6","author":"M Bari","year":"2006","unstructured":"Bari M., Battista N., Fezza F., Gasperi V., Maccarrone M (2006) New insights into endocannabinoid degradation and its therapeutic potential. Mini Rev Med Chem 6:257\u2013268","journal-title":"Mini Rev Med Chem"},{"key":"2362_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/FBP.0000000000000603","volume":"33","author":"LP Iglesias","year":"2022","unstructured":"Iglesias LP, Aguiar DC, Moreira FA (2022) TRPV1 blockers as potential new treatments for psychiatric disorders. Behav Pharmacol 33:2\u201314","journal-title":"Behav Pharmacol"},{"key":"2362_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0952-3278(95)90077-2","volume":"53","author":"V Di Marzo","year":"1995","unstructured":"Di Marzo V, Fontana A (1995) Anandamide, an endogenous cannabinomimetic eicosanoid:'killing two birds with one stone', Prostaglandins, leukotrienes and essential fatty acids. 53:1\u201311","journal-title":"Prostaglandins Leukotrienes Essential Fatty Acids"},{"key":"2362_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pharmthera.2007.01.005","volume":"114","author":"K Starowicz","year":"2007","unstructured":"Starowicz K., Nigam S., Di Marzo V. Biochemistry and pharmacology of endovanilloids. Pharmacol Ther (2007) : 114: 13\u201333","journal-title":"Pharmacol Ther"},{"key":"2362_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2217\/17455057.2.3.425","volume":"2","author":"DM Sloan","year":"2006","unstructured":"Sloan DM, Sandt AR (2006) Gender differences in depression. Women's Health 2:425\u2013434","journal-title":"Women's Health"},{"key":"2362_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.pneurobio.2019.01.006","volume":"176","author":"RS Eid","year":"2019","unstructured":"Eid R. S., Gobinath A. R., Galea L. A (2019) Sex differences in depression: Insights from clinical and preclinical studies. Prog Neurobiol 176:86\u2013102","journal-title":"Prog Neurobiol"},{"key":"2362_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.lfs.2012.06.009","volume":"92","author":"RM Craft","year":"2013","unstructured":"Craft R. M., Marusich J. A., Wiley J. L (2013) Sex differences in cannabinoid pharmacology: a reflection of differences in the endocannabinoid system? Life Sci 92:476\u2013481","journal-title":"Life Sci"},{"key":"2362_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1468-2982.2005.01031.x","volume":"26","author":"L Cupini","year":"2006","unstructured":"Cupini L., Bari M., Battista N., Argiro G., Finazzi-Agro A., Calabresi P. et al. (2006) Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. Cephalalgia 26:277\u2013281","journal-title":"Cephalalgia"},{"key":"2362_CR20","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.2174\/13816128113199990430","volume":"20","author":"M Paola Castelli","year":"2014","unstructured":"Paola Castelli M., Fadda P., Casu A., Sabrina Spano M., Casti A., Fratta W. et al. Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones. Curr Pharm Design 2014: 20: 2100\u20132113","journal-title":"Curr Pharm Design"},{"key":"2362_CR21","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.neuroimage.2007.10.053","volume":"39","author":"K Van Laere","year":"2008","unstructured":"Van Laere K., Goffin K., Casteels C., Dupont P., Mortelmans L., de Hoon J. et al (2008) Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F] MK-9470 PET. NeuroImage 39:1533\u20131541","journal-title":"NeuroImage"},{"key":"2362_CR22","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4088\/JCP.18m12202","volume":"80","author":"SH Kennedy","year":"2019","unstructured":"Kennedy SH, Lam RW, Milev RS, Downar RVBP (2019) Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients with major depressive disorder: a CAN-BIND-1 report. J Clin Psychiatry 80:2236","journal-title":"J Clin Psychiatry"},{"key":"2362_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-016-0785-x","volume":"16","author":"RW Lam","year":"2016","unstructured":"Lam R. W., Milev R., Rotzinger S., Andreazza A. C., Blier P., Brenner C. et al. (2016) Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry 16:1\u201313","journal-title":"BMC Psychiatry"},{"key":"2362_CR24","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan D. V., Lecrubier Y., Sheehan K. H., Amorim P., Janavs J., Weiller E. et al (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM\u2013IV and ICD\u201310. J Clin Psychiatry 59:22\u201333","journal-title":"J Clin Psychiatry"},{"key":"2362_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA., \u00c5sberg M (1979) A new depression scale designed to be sensitive to change. Br J psychiatry 134:382\u2013389","journal-title":"Br J psychiatry"},{"key":"2362_CR26","doi-asserted-by":"publisher","first-page":"115563","DOI":"10.1016\/j.psychres.2023.115563","volume":"330","author":"HK Kim","year":"2023","unstructured":"Kim H. K., Gon\u00e7alves V. F., Husain M. I., M\u00fcller D. J., Mulsant B. H., Zai G. et al (2023) Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorder, and schizophrenia. Psychiatry Res 330:115563","journal-title":"Psychiatry Res"},{"key":"2362_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/ijnp\/pyz066","volume":"23","author":"A Yrondi","year":"2020","unstructured":"Yrondi A., Fiori L. M., Frey B. N., Lam R. W., MacQueen G. M., Milev R. et al (2020) Association between side effects and blood microRNA expression levels and their targeted pathways in patients with major depressive disorder treated by a selective serotonin reuptake inhibitor, escitalopram: a CAN\u2013BIND\u20131 report. Int J Neuropsychopharmacol 23:88\u201395","journal-title":"Int J Neuropsychopharmacol"},{"key":"2362_CR28","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.addbeh.2018.11.005","volume":"90","author":"BT Kerridge","year":"2019","unstructured":"Kerridge BT, Chou SP, Pickering RP, Ruan WJ, Huang B, Jung J et al (2019) Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001\u20132002 and 2012\u20132013. Addict Behav 90:250\u2013257","journal-title":"Addict Behav"},{"key":"2362_CR29","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ygeno.2019.05.007","volume":"112","author":"O Affinito","year":"2020","unstructured":"Affinito O., Palumbo D., Fierro A., Cuomo M., De Riso G., Monticelli A. et al. (2020) Nucleotide distance influences co-methylation between nearby CpG sites. Genomics 112:144\u2013150","journal-title":"Genomics"},{"key":"2362_CR30","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1080\/15592294.2015.1115176","volume":"10","author":"D Saito","year":"2015","unstructured":"Saito D, Suyama M (2015) Linkage disequilibrium analysis of allelic heterogeneity in DNA methylation. Epigenetics 10:1093\u20131098","journal-title":"Epigenetics"},{"key":"2362_CR31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1093\/bioinformatics\/bts013","volume":"28","author":"D Wang","year":"2012","unstructured":"Wang D., Yan L., Hu Q., Sucheston L. E., Higgins M. J., Ambrosone C. B. et al (2012) IMA: an R package for high-throughput analysis of Illumina's 450K Infinium methylation data. Bioinformatics 28:729\u2013730","journal-title":"Bioinformatics"},{"key":"2362_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin A., Kormaksson M., LI S., Garrett-Bakelman F. E., Figueroa M. E., Melnick A. et al (2012) methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol 13:1\u20139","journal-title":"Genome Biol"},{"key":"2362_CR33","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41398-019-0589-0","volume":"9","author":"C Ju","year":"2019","unstructured":"Ju C., Fiori L. M., Belzeaux R., Theroux JF., Chen GG., Aouabed Z. et al (2019) Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants. Translational psychiatry 9:254","journal-title":"Translational psychiatry"},{"key":"2362_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M. A., Bender D. et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559\u2013575","journal-title":"Am J Hum Genet"},{"key":"2362_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41398-021-01248-3","volume":"11","author":"VS Marshe","year":"2021","unstructured":"Marshe V. S., Maciukiewicz M., Hauschild AC., Islam F., Qin L, Tiwari AK. et al (2021) Genome-wide analysis suggests the importance of vascular processes and neuroinflammation in late-life antidepressant response. Translational psychiatry 11:127","journal-title":"Translational psychiatry"},{"key":"2362_CR36","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/tpj.2017.29","volume":"18","author":"M Maciukiewicz","year":"2018","unstructured":"Maciukiewicz M, Marshe V, Tiwari A, Fonseka T, Freeman N, Kennedy J et al (2018) Genome-wide association studies of placebo and duloxetine response in major depressive disorder. Pharmacogenomics J 18:406\u2013412","journal-title":"Pharmacogenomics J"},{"key":"2362_CR37","first-page":"436","volume":"9","author":"R Joehanes","year":"2016","unstructured":"Joehanes R., Just AC., Marioni RE., Pilling LC., Reynolds LM., Mandaviya PR et al. (2016) Epigenetic signatures of cigarette smoking. Circulation: Cardiovasc Genet 9:436\u2013447","journal-title":"Circulation: Cardiovasc Genet"},{"key":"2362_CR38","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1471-2105-13-86","volume":"13","author":"EA Houseman","year":"2012","unstructured":"Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH et al (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86","journal-title":"BMC Bioinformatics"},{"key":"2362_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12859-017-1511-5","volume":"18","author":"AE Teschendorff","year":"2017","unstructured":"Teschendorff AE, Breeze CE, Zheng SC, Beck S (2017) A comparison of reference-based algorithms for correcting cell-type heterogeneity in Epigenome-Wide Association Studies. BMC Bioinformatics 18:105","journal-title":"BMC Bioinform"},{"key":"2362_CR40","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1093\/bioinformatics\/bts606","volume":"28","author":"X Zheng","year":"2012","unstructured":"Zheng X, Levine D, Shen J, Gogarten SM, Laurie C, Weir BS (2012) A high-performance computing toolset for relatedness and principal component analysis of SNP data. Bioinformatics 28:3326\u20133328","journal-title":"Bioinformatics"},{"key":"2362_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.psyneuen.2007.02.003","volume":"32","author":"MN Hill","year":"2007","unstructured":"Hill MN, Karacabeyli ES, Gorzalka BB (2007) Estrogen recruits the endocannabinoid system to modulate emotionality. Psychoneuroendocrinology 32:350\u2013357","journal-title":"Psychoneuroendocrinology"},{"key":"2362_CR42","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.neuroimage.2018.10.013","volume":"184","author":"H Laurikainen","year":"2019","unstructured":"Laurikainen H, Tuominen L., Tikka M., Merisaari H., Armio RL., Sormunen E et al. (2019) Sex difference in brain CB1 receptor availability in man. NeuroImage 184:834\u2013842","journal-title":"NeuroImage"},{"key":"2362_CR43","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/jcbfm.2015.46","volume":"35","author":"MD Normandin","year":"2015","unstructured":"Normandin MD, Zheng MQ, Lin KS, Mason NS, Lin SF, Ropchan J et al (2015) Imaging the cannabinoid CB1 receptor in humans with [11\u00a0C] OMAR: assessment of kinetic analysis methods, test\u2013retest reproducibility, and gender differences. J Cereb Blood Flow Metabolism 35:1313\u20131322","journal-title":"J Cereb Blood Flow Metabolism"},{"key":"2362_CR44","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1210\/en.2011-1643","volume":"153","author":"BB Gorzalka","year":"2012","unstructured":"Gorzalka BB, Dang SS (2012) Minireview: endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 153:1016\u20131024","journal-title":"Endocrinology"},{"key":"2362_CR45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1007\/s12264-021-00689-6","volume":"37","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Wu X, Zhou R., Sie O, Niu Z, Wang F (2021) Hypothalamic-pituitary-end-organ axes: hormone function in female patients with major depressive disorder. Neurosci Bull 37:1176\u20131187","journal-title":"Neurosci Bull"},{"key":"2362_CR46","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0306-4530(00)00050-0","volume":"26","author":"WH Meller","year":"2001","unstructured":"Meller WH, Grambsch PL, Bingham C, Tagatz GE (2001) Hypothalamic pituitary gonadal axis dysregulation in depressed women. Psychoneuroendocrinology 26:253\u2013259","journal-title":"Psychoneuroendocrinology"},{"key":"2362_CR47","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1210\/en.2004-1672","volume":"146","author":"CM Gammon","year":"2005","unstructured":"Gammon C. M., Freeman G. M., Xie W., Petersen S. L., Wetsel W. C (2005) Regulation of gonadotropin-releasing hormone secretion by cannabinoids. Endocrinology 146:4491\u20134499","journal-title":"Endocrinology"},{"key":"2362_CR48","doi-asserted-by":"publisher","first-page":"11891","DOI":"10.1073\/pnas.0404366101","volume":"101","author":"C Scorticati","year":"2004","unstructured":"Scorticati C, Fern\u00e1ndez-Solari J, De Laurentiis A, Mohn C, Prestifilippo JP, Lasaga M et al (2004) The inhibitory effect of anandamide on luteinizing hormone-releasing hormone secretion is reversed by estrogen. Proc Natl Acad Sci 101:11891\u201311896","journal-title":"Proc Natl Acad Sci"},{"key":"2362_CR49","doi-asserted-by":"publisher","first-page":"806417","DOI":"10.3389\/fphar.2021.806417","volume":"12","author":"AP Young","year":"2022","unstructured":"Young AP, Denovan-Wright EM (2022) The dynamic role of microglia and the endocannabinoid system in neuroinflammation. Front Pharmacol 12:806417","journal-title":"Front Pharmacol"},{"key":"2362_CR50","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.celrep.2014.11.001","volume":"9","author":"BC Shonesy","year":"2014","unstructured":"Shonesy BC, Bluett RJ, Ramikie TS, B\u00e1ldi R, Hermanson DJ, Kingsley PJ. Genetic disruption of 2\u2013arachidonoylglycerol synthesis reveals a key role for endocannabinoid signaling in anxiety modulation. Cell Rep 2014: 9: 1644\u20131653","journal-title":"Cell Rep"},{"key":"2362_CR51","doi-asserted-by":"publisher","first-page":"9248","DOI":"10.3390\/ijms22179248","volume":"22","author":"PW Gold","year":"2021","unstructured":"Gold PW (2021) The PPARg system in major depression: pathophysiologic and therapeutic implications. Int J Mol Sci 22:9248","journal-title":"Int J Mol Sci"},{"key":"2362_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fphar.2016.00446","volume":"7","author":"SC Piantadosi","year":"2016","unstructured":"Piantadosi SC, French BJ, Poe MM, Timi\u0107 T, Markovi\u0107 BD, Pabba M (2016) Sex-dependent anti-stress effect of an \u03b15 subunit containing GABAA receptor positive allosteric modulator. Front Pharmacol 7:446","journal-title":"Front Pharmacol"},{"key":"2362_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fgene.2018.00227","volume":"9","author":"J Nishino","year":"2018","unstructured":"Nishino J, Ochi H., Kochi Y., Tsunoda T., Matsui S. Sample size for successful genome-wide association study of major depressive disorder. Front Genet 2018: 9: 227","journal-title":"Front Genet"},{"key":"2362_CR54","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1194\/jlr.M021378","volume":"53","author":"F Fanelli","year":"2012","unstructured":"Fanelli F, Di Lallo VD, Belluomo I, De Iasio R, Baccini M, Casadio E et al. (2012) Estimation of reference intervals of five endocannabinoids and endocannabinoid related compounds in human plasma by two dimensional-LC\/MS\/MS. J Lipid Res 53:481\u2013493","journal-title":"J Lipid Res"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-026-02362-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-026-02362-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:02:17Z","timestamp":1789056137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-026-02362-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2362"],"URL":"https:\/\/doi.org\/10.1007\/s00406-026-02362-3","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Foster has served on the Scientific Advisory Board for MRM Health NL and has received consulting\/speaker fees from Alphasights, Rothman, Benson & Hedges Inc., Takeda Canada, and WebMD. Dr. Frey declares research contracts with Johnson & Johnson and Alcediag, and advisory board engagement with Johnson & Johnson and Eisai, outside of this work. Dr. Husain leads contracted research for Compass Pathfinder Limited. Dr. Kennedy has received honoraria for consulting or speaking engagements from Boehringer-Ingelheim, Brain Canada, Janssen, Lundbeck, Otsuka, and Servier. He has received research support from Brain Canada, the Canadian Institutes of Health Research (CIHR), Janssen, Lundbeck, Neurocrine, the Ontario Brain Institute, and Otsuka. He has participated in clinical trials sponsored by Compass, Denovo, and Janssen. Dr. Kloiber received honorarium for past consultation from EmpowerPharm. Dr. Lam has received honoraria for ad hoc speaking or advising\/consulting, or received research funds, from: Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, BetterUp, Brain Canada, Canadian Institutes of Health Research, Canadian Medical Protective Association, Canadian Network for Mood and Anxiety Treatments, Carnot, CB Solutions, Genome BC, Grand Challenges Canada, Lundbeck, Michael Smith Foundation for Health Research, Neurotorium, Ontario Brain Institute, Otsuka, Shanghai Mental Health Center, Unity Health, Vancouver Coastal Health Research Institute, and VGH-UBCH Foundation.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}